Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TENAX THERAPEUTICS, INC.

(TENX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 3,659,5123,548,4--
Entreprise Value (EV)1 3,659,5123,548,448,448,4
P/E ratio -0,13x-1,04x-1,40x-1,20x-21,3x-2,37x
Yield ------
Capitalization / Revenue ----1,94x1,94x
EV / Revenue ----1,94x1,94x
EV / EBITDA ---2 379 601x---
Price to Book ------
Nbr of stocks (in thousands) 3 0176 74212 61925 201--
Reference price (USD) 1,211,411,861,921,921,92
Last update 04/01/201903/30/202003/31/2021---
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 ----25,025,0
EBITDA ---9,86---
Operating profit (EBIT)1 -6,89-8,56-9,87-33,27,45-25,4
Operating Margin ----29,8%-102%
Pre-Tax Profit (EBT)1 -6,81-8,39-9,85-33,27,45-25,4
Net income1 -14,1-8,39-9,85-33,23,65-25,4
Net margin ----14,6%-102%
EPS2 -9,04-1,35-1,33-1,60-0,09-0,81
Dividend per Share ------
Last update 04/01/201903/30/202003/31/2021---
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -5,51-7,56-9,2826,7-15,523,7
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 0,010,00-1,000,101,00
Capex / Sales ----0,40%4,00%
Last update 04/01/201903/30/202003/31/202105/25/202105/25/202105/25/2021
1 USD in Million
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
48 386 519
Free-Float
67,0%
Free-Float capitalization (USD)
32 411 688
Avg. Exchange 20 sessions (USD)
161 650
Average Daily Capital Traded
0,33%
EPS & Dividend